Acute Decompensation of Liver Cirrhosis

1

Review clinical trials related to Acute Decompensation of Liver Cirrhosis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Phase 2 Study of 500 mg BID NTZ on Top of Standard of Care in Patients With Acute Decompensation of Liver Cirrhosis at High Risk of Progression to Acute-on-Chronic Liver Failure or Established Acute-on-Chronic Liver Failure

Phase 2 Study of 500 mg BID NTZ on Top of Standard of Care in Patients with Acute Decompensation of Liver Cirrhosis at High Risk of Progression to Acute-on-Chronic Liver Failure or Established Acute-on-Chronic Liver Failure

Participants needed: 16
Trial details
Phase: Phase 2Age: 18-74Biological sex: AllType: InterventionalSponsor: GenfitUpdated: Jul 9, 2026
Eligibility criteria

Participants with liver cirrhosis of any underlying etiology (liver cirrhosis di... [+4]

Known hypersensitivity to nitazoxanide or any known excipient of the IMP [+11]